Cover Image
市場調查報告書

Gamida Cell Ltd.的產品平台分析

Gamida Cell Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251667
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Gamida Cell Ltd.的產品平台分析 Gamida Cell Ltd. - Product Pipeline Review - 2015
出版日期: 2015年10月30日 內容資訊: 英文 21 Pages
簡介

Gamida Cell Ltd.是總公司設於以色列的醫療保健企業,提供白血病,淋巴瘤,克拉伯病,異染性腦白質退化症(MLD),賀勒氏症,血癌,末稍血管系疾病,神經系統疾病的治療藥。

本報告提供Gamida Cell Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Gamida Cell Ltd.的基本資料

  • Gamida Cell Ltd.概要
  • 主要資訊
  • 企業資料

Gamida Cell Ltd.:R&D概要

  • 主要的治療範圍

Gamida Cell Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Gamida Cell Ltd.:開發中產品概況

  • 後期階段產品開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Gamida Cell Ltd.:藥物簡介

  • StemEx
  • GC-003
  • NiCord
  • Stem Cells to Activate Natural Killer Cell for Adoptive Cell-Mediated Therapy
  • Mesenchymal Stem Cells for Immunology

Gamida Cell Ltd.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Gamida Cell Ltd.:最新的開發平台資訊

Gamida Cell Ltd.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07720CDB

Summary

Global Markets Direct's, 'Gamida Cell Ltd. - Product Pipeline Review - 2015', provides an overview of the Gamida Cell Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Gamida Cell Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Gamida Cell Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Gamida Cell Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Gamida Cell Ltd.'s pipeline products

Reasons to buy

  • Evaluate Gamida Cell Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Gamida Cell Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Gamida Cell Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Gamida Cell Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Gamida Cell Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Gamida Cell Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Gamida Cell Ltd. Snapshot
    • Gamida Cell Ltd. Overview
    • Key Information
    • Key Facts
  • Gamida Cell Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Gamida Cell Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Gamida Cell Ltd. - Pipeline Products Glance
    • Gamida Cell Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Gamida Cell Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Gamida Cell Ltd. - Drug Profiles
    • CordIn
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NiCord
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cell Therapy to Activate Natural Killer Cell for Adoptive Cell-Mediated Therapy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Gamida Cell Ltd. - Pipeline Analysis
    • Gamida Cell Ltd. - Pipeline Products by Route of Administration
    • Gamida Cell Ltd. - Pipeline Products by Molecule Type
  • Gamida Cell Ltd. - Recent Pipeline Updates
  • Gamida Cell Ltd. - Dormant Projects
  • Gamida Cell Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Gamida Cell Ltd., Key Information
  • Gamida Cell Ltd., Key Facts
  • Gamida Cell Ltd. - Pipeline by Indication, 2015
  • Gamida Cell Ltd. - Pipeline by Stage of Development, 2015
  • Gamida Cell Ltd. - Monotherapy Products in Pipeline, 2015
  • Gamida Cell Ltd. - Phase I, 2015
  • Gamida Cell Ltd. - Preclinical, 2015
  • Gamida Cell Ltd. - Pipeline by Route of Administration, 2015
  • Gamida Cell Ltd. - Pipeline by Molecule Type, 2015
  • Gamida Cell Ltd. - Recent Pipeline Updates, 2015
  • Gamida Cell Ltd. - Dormant Developmental Projects,2015

List of Figures

  • Gamida Cell Ltd. - Pipeline by Top 10 Indication, 2015
  • Gamida Cell Ltd. - Pipeline by Stage of Development, 2015
  • Gamida Cell Ltd. - Monotherapy Products in Pipeline, 2015
  • Gamida Cell Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Gamida Cell Ltd. - Pipeline by Top 10 Molecule Type, 2015
Back to Top